MedTrace Logo

Vascutek Anaconda™ Abdominal Aortic Aneurysm (AAA) Post-Market Surveillance Registry

NCT01744119 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 318

Last updated 2016-05-24

No results posted yet for this study

Summary

The purpose of this observational Post-Market Surveillance Registry is to gather post-market data on the performance of the CE marked Vascutek Anaconda™ Stent Graft System for the repair of Abdominal Aortic Aneurysms (AAA). The Study population consists of patients suitable for endovascular repair of AAA. Patients will be followed at 1, 3, 6, 12, 18, 24, 36, 48 and 60 months post-implantation.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

Vascutek Anaconda™ Stent Graft System

Sponsors & Collaborators

  • Vascutek Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Australia
  • France
  • Germany
  • Italy
  • New Zealand
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01744119 on ClinicalTrials.gov